Drug Profile
PF 3049423
Alternative Names: PF-03049423; PF3049423Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Pfizer
- Class Neuroprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Stroke
Most Recent Events
- 28 Feb 2014 Discontinued - Phase-II for Stroke in Bulgaria (PO)
- 28 Feb 2014 Discontinued - Phase-II for Stroke in Germany (PO)
- 28 Feb 2014 Discontinued - Phase-II for Stroke in Hungary (PO)